NOVOCURE LTD - NOTE 11/0

Historical Holders from Q4 2021 to Q3 2025

CUSIP
67011XAB9
Type / Class
Debt / NOTE 11/0
All holders as of September 30, 2025
Q3 2025
Total 13F principal, excl. options
562M
Holdings value
$558M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
20
Number of buys
10
Number of sells
-7
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NOVOCURE LTD - NOTE 11/0

Period Principal Value Change Price Investors
2025 Q3 $562M $558M +$18.4M $0.99 20
2025 Q2 $556M $544M -$6.06M $0.98 23
2025 Q1 $551M $536M -$2.91B $0.97 17
2024 Q4 $553M $528M -$17.4M $0.95 17
2024 Q3 $571M $540M +$371K $0.94 18
2024 Q2 $571M $526M -$7.85M $0.92 18
2024 Q1 $510M $466M +$19.4M $0.91 22
2023 Q4 $492M $428M +$298K $0.87 21
2023 Q3 $489M $425M +$25M $0.86 23
2023 Q2 $458M $396M +$28.2M $0.86 31
2023 Q1 $425M $369M -$36.6M $0.87 30
2022 Q4 $467M $417M +$10.3M $0.89 30
2022 Q3 $324M $298M -$85.8M $0.89 29
2022 Q2 $397M $345M -$95.2M $0.87 31
2022 Q1 $547M $498M +$25.5M $0.91 44
2021 Q4 $516M $474M +$474M $0.92 36